XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenues:        
Total revenues $ 69,514 $ 167,735 $ 176,688 $ 538,191
Operating expenses:        
Cost of sales - product 13,229 61,334 41,478 184,665
Research and development 14,116 12,962 40,767 33,746
Selling, general and administrative 38,053 32,042 111,667 100,393
Gain on sale of assets (Note 5) (1,000) 0 (1,000) (1,000)
Bad debt expense 0 0 12,313 0
Total operating expenses 64,398 106,338 205,225 317,804
Income from operations 5,116 61,397 (28,537) 220,387
Other income (expense):        
Interest income 8,462 2,562 22,437 3,588
Interest expense (1,691) (1,685) (5,065) (5,048)
Sublease income 1,993 2,026 5,584 5,660
Change in fair value of warrant liability (Note 10) 0 0 0 1,801
Other 266 (208) 218 (63)
Net income before income taxes 14,146 64,092 (5,363) 226,325
Provision for income taxes 147 (283) (1,245) (902)
Net income $ 14,293 $ 63,809 $ (6,608) $ 225,423
Net income per share attributable to common stockholders        
Basic $ 0.11 $ 0.5 $ (0.05) $ 1.79
Diluted $ 0.1 $ 0.43 $ (0.05) $ 1.51
Weighted-average shares used in computing net income per share attributable to common stockholders:        
Basic 128,988 127,062 128,515 125,997
Diluted 154,196 151,538 128,515 150,433
Product        
Revenues:        
Total revenues $ 62,318 $ 163,815 $ 162,209 $ 531,462
Other Revenue        
Revenues:        
Total revenues $ 7,196 $ 3,920 $ 14,479 $ 6,729